Search Results
Found 1 results
510(k) Data Aggregation
(209 days)
The Accurex Glucose Test Strip for use with the following glucometers: One Touchi Basic, OneTouch II and OneTouch Profile meters, all manufactured by Lifescan, Inc.
It is to be used for the quantitative measurement of glucose in fresh capillary whole blood. Glucose measurements are used as an aid to monitor the effectiveness of diabetes control.
The Accurex Glucose Test Strip is a generic replacement for the Lifescan One Touch Glucose Test Strip. These glucose test strips can be used with the following glucometers: One Touch Profile, One Touch II, One Touch Basic (with large screen), One Touch Basic (with small screen).
Here's an analysis of the provided text regarding the Accurex Glucose Test Strip, focusing on acceptance criteria and study details.
Important Note: The provided document is a 510(k) summary, which typically focuses on demonstrating substantial equivalence to a predicate device rather than presenting a detailed, standalone clinical trial report with specific acceptance criteria and detailed performance metrics as might be found in a more comprehensive study. Therefore, some of the requested information (especially about specific performance thresholds, full study design, and AI-related details) is not explicitly present in this type of regulatory submission.
Acceptance Criteria and Reported Device Performance
Acceptance Criteria Category | Reported Device Performance (Accurex Glucose Test Strip) |
---|---|
Substantial Equivalence | Demonstrated to be substantially equivalent to the predicate One Touch Glucose Test Strip (K923544) manufactured by Lifescan Inc. This implies the device meets the safety and effectiveness standards of the predicate. |
Indications for Use | Matches the predicate: Quantitative measurement of glucose in fresh capillary whole blood for use with One Touch, One Touch II, and One Touch Basic glucometers. Used as an aid to monitor the effectiveness of diabetes control. |
Technological Characteristics | Found to have similar technological characteristics to the predicate device in areas such as indications for use, target population, where used, method comparison, and technical comparison. This suggests performance within acceptable ranges compared to the predicate, though specific numerical criteria are not detailed. |
Study Details
-
Sample Size used for the test set and the data provenance:
- Test Set Sample Size: The document does not explicitly state the specific sample size used for the performance evaluation that demonstrated equivalence.
- Data Provenance: Not explicitly stated (e.g., country of origin). The document indicates performance comparison to a predicate device, which would typically involve testing of the new device. It is a regulatory submission for a medical device in the USA.
- Retrospective/Prospective: Not explicitly stated. For device validation, prospective testing is common, but the nature of this summary means such details are omitted.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable/Not provided. For a glucose test strip, the "ground truth" is typically established by comparative measurements against a laboratory reference method (e.g., a highly accurate glucose analyzer) rather than expert consensus on interpretation. The document mentions "method comparison" and "technical comparison," implying such a comparison was done.
-
Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not applicable/Not provided. Adjudication methods like 2+1 or 3+1 are typically used for subjective assessments (e.g., image interpretation by radiologists). For objective quantitative measurements like glucose levels, comparison to a reference method is standard.
-
If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- This is not applicable. The Accurex Glucose Test Strip is a standalone in-vitro diagnostic device for measuring glucose levels. It does not involve human readers interpreting results in the way an imaging AI device would, nor does it involve AI assistance for human performance.
-
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Yes, for this type of device, the performance evaluation would be a "standalone" assessment of the device's accuracy and precision compared to a reference method. The device itself (the test strip in conjunction with compatible glucometers) is the "algorithm only" in this context. The reported substantial equivalence is based on this standalone performance.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- The "ground truth" for a glucose test strip is typically established by comparing the device's readings to those obtained from a highly accurate laboratory reference method (e.g., a hexokinase method performed on a clinical chemistry analyzer). The summary mentions "method comparison," which supports this type of ground truth.
-
The sample size for the training set:
- Not applicable in the context of this device. Glucose test strips are primarily electrochemical or photometric devices; they do not typically undergo "training" like machine learning algorithms with a dedicated training set. Their performance is validated through analytical and clinical studies against known standards or reference methods.
-
How the ground truth for the training set was established:
- Not applicable, as there is no "training set" in the machine learning sense for this device.
Ask a specific question about this device
Page 1 of 1